Our central goal is to understand the molecular basis for the chemical regulation of gap junction. Our central goal is to understand the molecular basis for the chemical regulation of gap junctions and its implications on cell behavior. This project has been a part of the Program Project Grant since its inception in 1990. For the next funding period, we will focus on four Specific Aims: 1) To begin a characterization of the mechanisms of gap junction formation and regulation in cells expressing Cx40 and Cx43. Cx40 and Cx43 do not form heterotypic channels. Yet, if both cells express both connexins, complex channels are formed. Moreover, some agonists regulate one isotype but not the other. We will determine whether a heteromeric connexin interacts with an opposing homomer and if so, whether the regulation of channel is dominated by one of the connexins. 2) To determine the pH sensitivity of gap junctions in cells expressing Cx40 and Cx43. We recently demonstrated that """"""""hetero- domain interactions"""""""" between a truncated Cx40 and the heterologous CX43CT render the channel more pH sensitive than the wild-type Cx40. We therefore propose that in heteromeric Cx40-Cx43 gap junctions, hetero-domain interactions lead to synergism of pH grating. 3) To study the ability of connexin CT fragments to interfere with the chemical regulation of exogenous homomeric gap junctions. Previous studies show that injection of the entire Cx43CT fragment, or of a specific 17mer peptide to Cx43-expressing oocyte pairs can interfere with pH gating. Here, we will test whether these fragments can interfere with other regulatory functions of Cx43, or of Cx40. We will also seek to identify new peptides that interfere with Cx43 regulation. 4) To determine whether over-expression of the Cx43CT domain can lead to functional alterations in cell physiology and to the disruption of organ function. We have developed a transgenic mouse line that over-expressed the Cx43CT domain under the control of the cytomegaloviral (CMV) promoter (cardiac neural crest-targeted). We hypothesize that connexin fragments can disrupt tissue function without altering the expression of pore- forming proteins. Overall, we focus on how connexin-connexin interactions (between full-length molecules or between a connexin and a fragment) affect gap junction regulation. These studies will lead to a better understanding of the role of connexins in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL039707-11
Application #
6312803
Study Section
Project Start
2000-05-01
Project End
2001-04-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2000
Total Cost
$564,536
Indirect Cost
Name
Upstate Medical University
Department
Type
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe; Valdivia, Carmen R et al. (2018) Cardiac Kir2.1 and NaV1.5 Channels Traffic Together to the Sarcolemma to Control Excitability. Circ Res 122:1501-1516
Rodrigo, M; Climent, A M; Liberos, A et al. (2017) Minimal configuration of body surface potential mapping for discrimination of left versus right dominant frequencies during atrial fibrillation. Pacing Clin Electrophysiol 40:940-946
Rodrigo, Miguel; Climent, Andreu M; Liberos, Alejandro et al. (2017) Highest dominant frequency and rotor positions are robust markers of driver location during noninvasive mapping of atrial fibrillation: A computational study. Heart Rhythm 14:1224-1233
Quintanilla, Jorge G; Pérez-Villacastín, Julián; Pérez-Castellano, Nicasio et al. (2016) Mechanistic Approaches to Detect, Target, and Ablate the Drivers of Atrial Fibrillation. Circ Arrhythm Electrophysiol 9:e002481
Takemoto, Yoshio; Ramirez, Rafael J; Yokokawa, Miki et al. (2016) Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes. JACC Basic Transl Sci 1:143-154
Filgueiras-Rama, David; Jalife, José (2016) STRUCTURAL AND FUNCTIONAL BASES OF CARDIAC FIBRILLATION. DIFFERENCES AND SIMILARITIES BETWEEN ATRIA AND VENTRICLES. JACC Clin Electrophysiol 2:1-3
Pedrón-Torrecilla, Jorge; Rodrigo, Miguel; Climent, Andreu M et al. (2016) Noninvasive Estimation of Epicardial Dominant High-Frequency Regions During Atrial Fibrillation. J Cardiovasc Electrophysiol 27:435-42
Herron, Todd J; Rocha, Andre Monteiro Da; Campbell, Katherine F et al. (2016) Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function. Circ Arrhythm Electrophysiol 9:e003638
Guillem, María S; Climent, Andreu M; Rodrigo, Miguel et al. (2016) Presence and stability of rotors in atrial fibrillation: evidence and therapeutic implications. Cardiovasc Res 109:480-92
Willis, B Cicero; Pandit, Sandeep V; Ponce-Balbuena, Daniela et al. (2016) Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 133:2348-59

Showing the most recent 10 out of 257 publications